Slide 1: Connecting for a healthier future
Connecting for a healthier future T H E C I G N A G R O U P I N V E S TO R P R E S E N TAT I O N NOVEMBER 2, 2023 © 2023 The Cigna Group
Slide 2: Forward-looking statements
Forward-looking statements CAUTIONARY STATEMENT FOR PURPOSES OF THE “SAFE HARBOR” PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 This press release, and oral statements made in connection with this release, may contain forward-looking statements within the meaning of the Private
Slide 3: Non-GAAP measures and other key financial information
Non-GAAP measures and other key financial information Throughout this presentation, the term “adjusted earnings” means adjusted income (loss) from operations, and “adjusted earnings per share” or “adjusted EPS” means adjusted income (loss) from operations on a diluted per share basis. Adjusted incom
Slide 4: Connecting for a healthier future
Connecting for a healthier future Purpose and mission Well-positioned growth platforms Long-term framework Quarter results 2023 full year guidance 4 © 2023 The Cigna Group
Slide 5: To improve the health and vitality of those we serve
OUR PURPOSE AND MISSION To improve the health and vitality of those we serve. 5 © 2023 The Cigna Group
Slide 6: Two well-positioned growth platforms
Two well-positioned growth platforms Portfolio of health services Suite of health benefits Provides coordinated and point solution health Provides comprehensive medical services and capabilities to health plans, employers, and coordinated solutions to clients government organizations and health care
Slide 7: Our pathways to growth
Our pathways to growth FOUNDATIONAL ACCELERATED CROSS-ENTERPRISE GROWTH GROWTH LEVERAGE Scaled businesses contributing High-growth businesses A focus on working together steady, predictable growth in very attractive markets to create even greater value • Pharmacy Benefit Services • Specialty Pharmac
Slide 8: Enterprise leverage – deepening relationships
Enterprise leverage – deepening relationships Cigna Healthcare total cost of care impacted by Evernorth Health Services Enterprise leverage expected to create ~30% ~50% today long-term opportunity $10B – 20B of additional Evernorth Health Services revenue 8 © 2023 The Cigna Group
Slide 9: Expected cash flow generation and capital deployment framework
Expected cash flow generation and capital deployment framework ~$10B ~40% long-term target debt-to-capitalization ratio capital expenditures and surplus ~$50B to fund growth 2022–2026 cash flow from operations ~$40B STRATEGIC M&A ~20% dividend Strategically aligned ~10% repay debt Financially attrac
Slide 10: Strong long-term shareholder value
Strong 6 – 8% long-term targeted average annual adjusted earnings growth long-term long-term targeted average shareholder + 4 – 5% annual contribution from accretive capital deployment value = 10 – 13% long-term targeted average annual adjusted EPS growth PLUS AN ATTRACTIVE DIVIDEND Dividends are su
Slide 11: 3Q23 Results
3Q23 Results EPS Revenue and medical customers Key ratios Adjusted EPS* $6.77 Total revenues $49.0B Medical care ratio 80.5% Total medical customer 19.6M Adjusted SG&A expense ratio 7.3% Medical customer Adjusted income from operations YTD growth 1.6M Debt-to-capitalization ratio 40.5% Enterprise, a
Slide 12: 2023 Full year guidance
OPTION 2 2023 Full year guidance EPS Revenue and medical customers Key ratios At least 81.5% - Adjusted EPS At least $24.75 Adjusted revenues Medical care ratio $192.0B 82.0% At least Total medical customer growth Adjusted SG&A expense ratio ~7.4% 1.6M 20.5% - Adjusted income from operations Adjuste
Slide 13: Appendix
Appendix 13 © 2023 The Cigna Group
Slide 14: Definitions of key financial and business terms
Definitions of key financial and business terms Medical care ratio represents medical costs as a percentage of premiums for all U.S. Commercial risk products, including medical, pharmacy, dental, stop loss and behavioral products provided through guaranteed cost or experience-rated funding arrangeme
Slide 15: Reconciliation of GAAP to non-GAAP financial measures
Reconciliation of GAAP to non-GAAP financial measures Shareholders’ net income and diluted earnings per share Three Months Ended Sep 30, 2023 Dollars in millions Diluted earnings per share Pre-Tax After-Tax Pre-Tax After-Tax Shareholders’ net income $1,408 $4.74 Adjustments to reconcile to adjusted